1. Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission
   Catherine S.M. Diefenbach et al, 2008, Clinical Cancer Research CrossRef
2. Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer
   Marco Greppi et al, 2019, International Journal of Molecular Sciences CrossRef
3. Treatment of Metastatic or High-Risk Solid Cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports
   Andrea Nicolini et al, 2019, International Journal of Molecular Sciences CrossRef